Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Security class unavailable · CUSIP: 38000Q102
Event date: 2020-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 39,273
- Percent of class
- 0.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-20-000361
- Form type
- SC 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Jul 10, 2020
- Reporting period
- Jun 30, 2020
- Description
- Schedule 13G beneficial ownership